b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29339216</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>01</Month>\n            <Day>15</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>01</Month>\n            <Day>15</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1096-0279</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>145</Volume>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>05</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Protein expression and purification</Title>\n                <ISOAbbreviation>Protein Expr. Purif.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>In vivo biotinylated calpastatin improves the affinity purification of human m-calpain.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>77-84</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S1046-5928(17)30697-6</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pep.2018.01.002</ELocationID>\n            <Abstract>\n                <AbstractText>Recently we established a novel affinity purification method for calpain by exploiting the specific and reversible binding properties of its intrinsically disordered protein inhibitor, calpastatin. The immobilization strategy relied on the strength and specificity of the biotin - streptavidin interaction. Here, we report an improved and optimized method that even enables the general applicability of in vivo biotinylated (intrinsically disordered) proteins in any affinity capture strategy. Since in vitro chemical biotinylation is only accomplished with reagents that lack exact site specificity, it can not only cause sample heterogeneity but it can also hamper the functionality of the biotinylated molecules. Therefore, we have developed a recombinant expression protocol to produce in vivo biotinylated human calpastatin domain 1 (hCSD1) in Escherichia coli. We have experimentally verified that the biotinylated polypeptide tag is compatible with the intrinsically disordered state of hCSD1 and that it does not influence the functional properties of this intrinsically disordered protein (IDP). The in vivo biotinylated hCSD1 was then used without the need of any prepurification step prior to the affinity capturing of its substrate, human m-calpain. This leads to a simplified purification strategy that allows capturing the calpain efficiently from a complex biological mixture with only a single chromatogaphic step and in a considerably reduced timeframe. Our approach is generally applicable through the in vivo biotinylation of any IDP of interest, and its practical implementation will showcase the power to exploit the properties of IDPs in affinity capture strategies.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2018 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Nguyen</LastName>\n                    <ForeName>Hung Huy</ForeName>\n                    <Initials>HH</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>VIB - VUB Centre for Structural Biology (VIB CSB), Vlaams Instituut voor Biotechnologie (VIB), Brussels, Belgium; Structural Biology Brussels (SBB), Department of Biotechnology (DBIT), Vrije Universiteit Brussel (VUB), Brussels, Belgium.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Volkov</LastName>\n                    <ForeName>Alexander N</ForeName>\n                    <Initials>AN</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>VIB - VUB Centre for Structural Biology (VIB CSB), Vlaams Instituut voor Biotechnologie (VIB), Brussels, Belgium; Structural Biology Brussels (SBB), Department of Biotechnology (DBIT), Vrije Universiteit Brussel (VUB), Brussels, Belgium; Jean Jeener NMR Centre, Vrije Universiteit Brussel (VUB), Brussels, Belgium.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Vandenbussche</LastName>\n                    <ForeName>Guy</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Laboratory for the Structure and Function of Biological Membranes, Centre for Structural Biology and Bioinformatics, Universit\xc3\xa9 Libre de Bruxelles (ULB), Brussels, Belgium.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Tompa</LastName>\n                    <ForeName>Peter</ForeName>\n                    <Initials>P</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>VIB - VUB Centre for Structural Biology (VIB CSB), Vlaams Instituut voor Biotechnologie (VIB), Brussels, Belgium; Structural Biology Brussels (SBB), Department of Biotechnology (DBIT), Vrije Universiteit Brussel (VUB), Brussels, Belgium; Institute of Enzymology, Research Centre for Natural Sciences of the Hungarian Academy of Sciences, Budapest, Hungary.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pauwels</LastName>\n                    <ForeName>Kris</ForeName>\n                    <Initials>K</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>VIB - VUB Centre for Structural Biology (VIB CSB), Vlaams Instituut voor Biotechnologie (VIB), Brussels, Belgium; Structural Biology Brussels (SBB), Department of Biotechnology (DBIT), Vrije Universiteit Brussel (VUB), Brussels, Belgium. Electronic address: kris.pauwels@vub.be.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>01</Month>\n                <Day>13</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Protein Expr Purif</MedlineTA>\n            <NlmUniqueID>9101496</NlmUniqueID>\n            <ISSNLinking>1046-5928</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>9013-20-1</RegistryNumber>\n                <NameOfSubstance UI="D019809">Streptavidin</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 3.4.22.-</RegistryNumber>\n                <NameOfSubstance UI="D002154">Calpain</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 3.4.22.-</RegistryNumber>\n                <NameOfSubstance UI="C449000">m-calpain</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D019921" MajorTopicYN="N">Biotinylation</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002154" MajorTopicYN="N">Calpain</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>\n                <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002846" MajorTopicYN="N">Chromatography, Affinity</DescriptorName>\n                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName>\n                <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019809" MajorTopicYN="N">Streptavidin</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">Affinity chromatography</Keyword>\n            <Keyword MajorTopicYN="Y">AviTag</Keyword>\n            <Keyword MajorTopicYN="Y">BAP-tag</Keyword>\n            <Keyword MajorTopicYN="Y">Biotin ligase</Keyword>\n            <Keyword MajorTopicYN="Y">BirA</Keyword>\n            <Keyword MajorTopicYN="Y">Calpain-2</Keyword>\n            <Keyword MajorTopicYN="Y">IDP</Keyword>\n            <Keyword MajorTopicYN="Y">Protein co-expression</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2017</Year>\n                <Month>11</Month>\n                <Day>15</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2017</Year>\n                <Month>12</Month>\n                <Day>14</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>01</Month>\n                <Day>05</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>1</Month>\n                <Day>18</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>1</Month>\n                <Day>16</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>1</Month>\n                <Day>18</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29339216</ArticleId>\n            <ArticleId IdType="pii">S1046-5928(17)30697-6</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.pep.2018.01.002</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'